자동 로그아웃 안내

로그아웃 아이콘

로그아웃 시간이 남았습니다.
로그인 시간을 연장하시겠습니까?

로그아웃을 연장하시려면 아래 연장하기 버튼을 눌러주세요.

본문 바로가기

연구소

연구논문

  • Home
  • 연구소
  • 연구논문

논문성과

암센터 국문 논문 목록
학술지 책임저자
제1저자
저자,논문명,학술지명,발간일;년도;페이지:통권(Impact Factor)
The online promotion strategies of e-cigarette and heated tobacco product retailers in South Korea following the COVID-19 pandemic: Implications for regulation 강은교
(암검진사업부)
강은교:HyoRim Ju:이혜원, 최주영, Soojeong Kim. The online promotion strategies of e-cigarette and heated tobacco product retailers in South Korea following the COVID-19 pandemic: Implications for regulation Tobacco Induced Diseases. 2024-02-14; 2024; 22:37~. IF 2.2 (2023)
HyoRim Ju
Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy 한지연1
(치료내성연구과)
한지연:김선신, 이영주:송보람, 심한나, Eun Hye Kang, 황미화, 유남희, 홍세화, 박찬이, 안병철, 임은진, 황금희, 박석연, 최진호, 이건국. Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy Cancers. 2024-02-14; 2024; 16(4):778~. IF 4.5 (2023)
김선신
(표적치료연구과)
이영주
(표적치료연구과)
A Narrative Review of the 2023 Korean Thyroid Association Management Guideline for Patients with Thyroid Nodules Young Joo Park
Young Joo Park:이은경:Chan Kwon Jung, Dong Gyu Na. A Narrative Review of the 2023 Korean Thyroid Association Management Guideline for Patients with Thyroid Nodules Endocrinology and Metabolism. 2024-02-14; 2024; 39(1):61~72. IF 3.9 (2023)
이은경2
(표적치료연구과)
Application of plasma circulating KRAS mutations as a predictive biomarker for targeted treatment of pancreatic cancer 김윤희
(분자영상연구과)
공선영
(표적치료연구과)
김윤희, 공선영:이미림, 우상명:Min Kyeong Kim, 한성식,박상재,이우진, 이동은, Sun Il Choi, 최원영, 전중원. Application of plasma circulating KRAS mutations as a predictive biomarker for targeted treatment of pancreatic cancer CANCER SCIENCE. 2024-02-13; 2024; 115(4):1283~1295. IF 4.5 (2023)
이미림
(분자영상연구과)
우상명
(종양면역연구과)
Toward Deploying a Deep Learning Model for Diagnosis of Rhabdomyosarcoma Meera R. Hameed
Meera R. Hameed:Ho David Joon, Narasimhan P. Agaram:. Toward Deploying a Deep Learning Model for Diagnosis of Rhabdomyosarcoma MODERN PATHOLOGY. 2024-02-08; 2024; 37(3):100421~. IF 7.1 (2023)
Ho David Joon
(암AI디지털헬스학과)
Impact of Coronavirus Disease 2019 on Cancer Care: How the Pandemic has Changed Cancer Utilization and Expenditures 김영애
(암관리정책부)
김영애:Jinah Sim, Jihye Shin:이현정, 이연승. Impact of Coronavirus Disease 2019 on Cancer Care: How the Pandemic has Changed Cancer Utilization and Expenditures PLoS One. 2024-02-08; 2024; 19(2):e0296808~. IF 2.9 (2023)
Jinah Sim, Jihye Shin
Coagulation Testing in Real-World Setting: Insights From a Comprehensive Survey 공선영
(표적치료연구과)
공선영, Sang Mee Hwang:Hae In Bang, Ja Young Lee, Sang Mee Hwang, 공선영:. Coagulation Testing in Real-World Setting: Insights From a Comprehensive Survey CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS. 2024-02-06; 2024; 30:1~9. IF 2.3 (2023)
공선영
(표적치료연구과)
Cancer risk following Smoking cessation in Korea 오진경
(임상간호학과)
오진경:박은정:강희연, Min Kyung Lim, 김병미. Cancer risk following Smoking cessation in Korea JAMA Network Open. 2024-02-06; 2024; 7(2):e2354958~. IF 10.5 (2023)
박은정
(암관리학과)
The Efficacy and Safety of an Indocyanine Green-Macroaggregated Albumin-Hyaluronic Acid Mixture (LuminoMark™) for Surgical Localization of Recurrent Thyroid Cancer 정유석
(암데이터과학연구부)
정유석:김석기, Jungirl Seok:이창윤, 유창환, 최성용, 박석연, 이영기, 황보율, 이은경, 이유진, 박소현, 김태성, 김태현, 류준선. The Efficacy and Safety of an Indocyanine Green-Macroaggregated Albumin-Hyaluronic Acid Mixture (LuminoMark™) for Surgical Localization of Recurrent Thyroid Cancer ANNALS OF SURGICAL ONCOLOGY. 2024-02-02; 2024; 31:2349~2356. IF 3.4 (2023)
김석기
(분자영상연구과)
Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real-world multicenter cohort study Yoon Jun Kim
Yoon Jun Kim:Hyunjae Shin, Seung Up Kim, Byeong Geun Song:Youngsu Park, Yunmi Ko, Jeayeon Park, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Dong Hyun Sinn. Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real-world multicenter cohort study HEPATOLOGY RESEARCH. 2024-02-01; 2024; 54(7):627~637. IF 3.9 (2023)
신현재
(소화기내과분과)